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Supplementary Table S1  Supplementary Table S2  Supplementary Table S3 Supplementary Figure Name of the targeted gene (and AICS cell line identifier used in the cell line catalog at Allen Cell Explorer and the Allen Cell Collection at Coriell), crRNA number, HDR efficiency, and binding sequence are shown. Percent HDR was determined by FACS and is shown as a percentage of GFP+ cells within the gated cell population in each experiment. The crRNA used to create the final clone chosen for expansion and distribution for each gene is bolded and underlined. The non-complementary DNA strand corresponding to the crRNA binding site and PAM in the WTC genome is shown in black. The non-complementary DNA strand corresponding to the crRNA binding site in the donor plasmid and PAM is shown in red. Mutations introduced into the donor plasmid to eliminate Cas9 cleavage are indicated by lower case (point mutations), dashes (deletions), or forward slash (where the tag and linker sequence interrupts the crRNA binding site). The distance between the intended insertion site and the PAM -3 site (where double strand breaks are anticipated) is indicated for each crRNA. Distances are negative when the double strand break is anticipated 5′ of the insertion site and positive when the double strand break is anticipated 3′ of the insertion site relative to gene orientation. Gene orientation and crRNA orientation are defined according to strand in the GRCh38 reference genome. Genomic coordinates are indicated for the site of integration, and for single nucleotide polymorphisms (SNPs) and insertions or deletions (INDELs) specific to the WTC genome within the homology arm region of the plasmid. In cases where the WTC-specific SNP was heterozygous, the reference genome variant was used in the homology arm. Coordinates are from the GRCh38 (GCA 000001405.15) assembly, NCBI annotation 107. *TUBG1 heterozygous SNP was changed to WTC variant in donor plasmid.
Table S2. PCR primers used in experiments.
All primers are listed in 5′ to 3′ orientation. Figure S1 . Expression levels of the 12 genes attempted for genome editing in the WTC parental cell line. Transcript abundance for each gene was estimated from RNA-Seq data. Samples were derived from the WTC parental line after 8 passages (p8) in culture and 14 passages (p14) in culture, as indicated. Transcript abundances were calculated in units of fragments per kilobase of transcript per million fragments mapped (FPKM). Log10 (FPKM+1) transcript abundances from parental WTC p8 and p14 samples were plotted against each other and were highly correlated (R 2 = 0.989). The two genes (TUBG1 and GALT) that were not successfully edited are highlighted in red. Each predicted off-target sequence was categorized according to its sequence profile (the number of mismatches and RNA or DNA bulges it contains relative to the crRNA used in the experiment and their position relative to the PAM). Cas-OFFinder was used to identify all alternative sites genome-wide with ≤2 mismatches/bulges in the non-seed and/or ≤1 mismatch/bulge in the seed region, with an NGG or NAG PAM. As indicated, the seed and non-seed region of a crRNA binding sequence was defined with respect to its proximity to the PAM sequence. Overlapping Cas-OFFinder results with the same double strand break site were collapsed into one category using sequence profile ranking (see Methods). Fig. 2A step  1 ). Each data point represents one clone. Clones with GFP genomic copy number of ~1 to ~2 and plasmid backbone genomic copy number <0.2 were typically considered for further analysis. TJP1 clones consistently produced GFP copy number values <1 despite validation by junctional PCR, imaging and western blot as putative mono-allelic clones. This result is unresolved and under investigation. (B) A dilution series of the donor plasmid used for the PXN-EGFP tagging experiment was used to confirm equivalent amplification of the AMP and GFP sequences in twochannel ddPCR assays. anti-myosin IIB antibody staining FOV showing apical and basal regions. Images represent maximum intensity projections of 4 apical or basal z-sections of the cell colony. Scale bars are 10 µm. All images acquired on a spinning disk confocal microscope except panels shown for desmoplakin, which was acquired on a laser scanning confocal microscope. Antibody and method details are available in Table S3 and the Allen Cell Explorer (Allen Institute for Cell Science, 2017). Table S3 . Figure S9 . Editing experiments testing the feasibility of biallelic editing of the LMNB1 and TUBA1B loci. (A) Final clones LMNB1-mEGFP and TUBA1B-mEGFP were transfected using the standard editing protocol with a donor cassette targeting the untagged allele of the tagged locus, encoding mTagRFP-T (sequential delivery, top row). Additionally, unedited cells were transfected with editing reagents according to the standard editing protocol, using a 1:1 mix of the mEGFP and mTagRFP-T donor plasmids (simultaneous delivery, bottom row). Flow cytometry was used to identify cells with mono-allelic edits (either tag), as well as cells with biallelic editing (both tags). Frequency of editing with mTagRFP-T was quantified by flow cytometry. mTagRFP-T+ LMNB1-mEGFP cells were isolated by FACS (asterisk denotes sorted population). (B) The sorted population from (A) (indicated by asterisk) revealed similar subcellular localization of GFP and mTagRFP-T signal to the nuclear envelope in the majority of cells, suggesting successful biallelic tagging. Scale bars are as indicated in the merged panels. Cells were fixed in 4% paraformaldehyde before imaging. Low magnification images (top row) reveal that sorting significantly enriches the population for mTagRFP-T+ cells, which vary in mTagRFP-T intensity. This pattern was also seen with LMNB1-mEGFP+ sorted cells (Fig. 1E ) before clones were selected. Final tagged clones from four experiments in which the tagged protein copy displayed diminished abundance relative to the untagged copy, in addition to TUBA1B-mEGFP clones, were compared to independently derived clones from the same experiment that were also validated as correctly edited. All clones were blotted both with anti-GFP and with antibodies recognizing the targeted protein, as indicated. Additionally, the final clone from each experiment was analyzed by immunoblot in the same manner in otherwise identical cultures separated by 4 passages (14 days) of culture time. The fraction of GFP-tagged protein, relative to total, is indicated. 
